Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Return on Equity (2016 - 2025)

Sanara MedTech's Return on Equity history spans 12 years, with the latest figure at 6.13% for Q4 2025.

  • For Q4 2025, Return on Equity fell 592.0% year-over-year to 6.13%; the TTM value through Dec 2025 reached 6.13%, down 592.0%, while the annual FY2025 figure was 1.66%, 147.0% down from the prior year.
  • Return on Equity reached 6.13% in Q4 2025 per SMTI's latest filing, down from 1.88% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.1% in Q4 2023 to a low of 6.13% in Q4 2025.
  • Average Return on Equity over 5 years is 0.57%, with a median of 0.2% recorded in 2023.
  • Peak YoY movement for Return on Equity: soared 87bps in 2021, then tumbled -592bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.24% in 2021, then increased by 26bps to 0.18% in 2022, then surged by 44bps to 0.1% in 2023, then crashed by -104bps to 0.2% in 2024, then plummeted by -2905bps to 6.13% in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Return on Equity are 6.13% (Q4 2025), 1.88% (Q3 2025), and 0.22% (Q2 2025).